Mumbai, India has emerged as a key hub for the supply of Acalabrutinib Active Pharmaceutical Ingredient (API), with several companies focused on its creation . Notably, certain manufacturers in this region are recognized for their high-quality Acalabrutinib (CAS 1420477-60-6) production, offering a reliable source for pharmaceutical companies world